The Cigna Group Demonstrates Robust Growth in 2025 Results with Positive 2026 Outlook
On February 5, 2026, The Cigna Group (NYSE: CI) declared robust financial performance for the fourth quarter and full year of 2025, highlighting a remarkable strategy focused on operational discipline and a diverse business portfolio. In a significant announcement, the company revealed that total revenues for 2025 surged to $274.9 billion, representing an 11% increase from the previous year. The net income attributable to shareholders reached $6.0 billion, translating to $22.18 per share, a notable improvement from the $3.4 billion or $12.12 per share achieved in 2024,
CEO David M. Cordani emphasized the company's commitment to broadening access and transparency for customers, stating, "In 2025, we expanded access and support, lowered costs, and improved transparency for our customers and patients." This clear momentum positions Cigna well as they move into 2026, with anticipated adjusted income from operations expected to exceed $7.95 billion, or at least $30.25 per share. Further enhancing shareholder value, the Board of Directors declared an increase in the quarterly dividend to $1.56 per share.
In examining segment performance, Cigna's Evernorth Health Services, encompassing Pharmacy Benefit Services and Specialty Care Services, showcased strong contributions to the financial results. In the fourth quarter alone, adjusted revenues saw a dramatic jump of 17% year-over-year, while adjusted income from operations increased slightly by 2%. The company attributed this success to existing client growth and new business acquisitions, which reflect ongoing strengths in their client relationships within the healthcare sector.
Cigna Healthcare, responsible for U.S. and International Health operations, reported total adjusted revenues of $47.2 billion in 2025, though this reflects a decline compared to the previous year—primarily due to the divestiture of Medicare and related businesses. Despite these challenges, fourth quarter performance improved significantly, indicating a positive trajectory for future growth.
Total customer relationships increased by 3% year-over-year, mirroring the company's ambition to enhance its offerings in the pharmacy and behavioral care sectors. Cigna experienced a notable rise in pharmacy customers, highlighting its effectiveness in expanding its services, with 123.6 million customers at year-end 2025.
Looking ahead, The Cigna Group is optimistic about its 2026 outlook, projecting around $280 billion in adjusted revenues and maintaining an adjusted SGA expense ratio of approximately 5%. The company plans strategic share repurchases and anticipates approximately $1.6 billion in shareholder dividends, underscoring its commitment to returning value to its investors.
Cigna’s forward-looking statements reflect a foundation built on resilience and a robust operational model, addressing the evolving needs in the healthcare landscape while ensuring strong financial returns. Buying back 11.9 million shares for about $3.6 billion in 2025 is a testament to their evaluation of stock value and long-term growth strategies.
As The Cigna Group aims for further growth, stakeholders and investors alike are encouraged to monitor how the company leverages its strong financial base to adapt and innovate in the healthcare marketplace, securing a healthier future for its clientele and communities. As they embark on this journey, the anticipation is high for the advancements that will further solidify Cigna's status as a leader in global health services.
CEO David M. Cordani emphasized the company's commitment to broadening access and transparency for customers, stating, "In 2025, we expanded access and support, lowered costs, and improved transparency for our customers and patients." This clear momentum positions Cigna well as they move into 2026, with anticipated adjusted income from operations expected to exceed $7.95 billion, or at least $30.25 per share. Further enhancing shareholder value, the Board of Directors declared an increase in the quarterly dividend to $1.56 per share.
In examining segment performance, Cigna's Evernorth Health Services, encompassing Pharmacy Benefit Services and Specialty Care Services, showcased strong contributions to the financial results. In the fourth quarter alone, adjusted revenues saw a dramatic jump of 17% year-over-year, while adjusted income from operations increased slightly by 2%. The company attributed this success to existing client growth and new business acquisitions, which reflect ongoing strengths in their client relationships within the healthcare sector.
Cigna Healthcare, responsible for U.S. and International Health operations, reported total adjusted revenues of $47.2 billion in 2025, though this reflects a decline compared to the previous year—primarily due to the divestiture of Medicare and related businesses. Despite these challenges, fourth quarter performance improved significantly, indicating a positive trajectory for future growth.
Total customer relationships increased by 3% year-over-year, mirroring the company's ambition to enhance its offerings in the pharmacy and behavioral care sectors. Cigna experienced a notable rise in pharmacy customers, highlighting its effectiveness in expanding its services, with 123.6 million customers at year-end 2025.
Looking ahead, The Cigna Group is optimistic about its 2026 outlook, projecting around $280 billion in adjusted revenues and maintaining an adjusted SGA expense ratio of approximately 5%. The company plans strategic share repurchases and anticipates approximately $1.6 billion in shareholder dividends, underscoring its commitment to returning value to its investors.
Cigna’s forward-looking statements reflect a foundation built on resilience and a robust operational model, addressing the evolving needs in the healthcare landscape while ensuring strong financial returns. Buying back 11.9 million shares for about $3.6 billion in 2025 is a testament to their evaluation of stock value and long-term growth strategies.
As The Cigna Group aims for further growth, stakeholders and investors alike are encouraged to monitor how the company leverages its strong financial base to adapt and innovate in the healthcare marketplace, securing a healthier future for its clientele and communities. As they embark on this journey, the anticipation is high for the advancements that will further solidify Cigna's status as a leader in global health services.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.